Alvotech Q4 Earnings Call Highlights [Yahoo! Finance]
Alvotech (ALVO)
Company Research
Source: Yahoo! Finance
Alvotech (NASDAQ:ALVO) executives used the company's fourth-quarter and full-year 2025 earnings call to outline progress on commercial launches, manufacturing and quality initiatives tied to recent U.S. regulatory setbacks, and a 2026 outlook that assumes continued growth outside the United States. 2025 highlights and leadership transition Founder and Executive Chairman Róbert Wessman said 2025 strengthened Alvotech's position “as one of the leading global developers of biosimilars,” pointing to an expanded commercial footprint, pipeline advancement, capital markets activity, and a Nasdaq Stockholm listing. Management also emphasized a “comprehensive quality improvement program” implemented after an FDA inspection of the Reykjavik manufacturing facility. ? Dollar Tree Planted the Seeds for Triple-Digit Gains in Q4 2 Generic Drug Makers With Growing Runways Wessman said the company expects to resubmit affected applications to the FDA during the second quarter of 2026, and sa
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech (ALVO) had its price target lowered by UBS Group AG from $10.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
- Alvotech (ALVO) had its price target lowered by Barclays PLC from $5.00 to $4.00. They now have an "underweight" rating on the stock.MarketBeat
- Alvotech (ALVO) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Did Alvotech's (ALVO) Profitability Turn and Expanding Biosimilar Pipeline Just Recast Its Investment Narrative? [Yahoo! Finance]Yahoo! Finance
- Alvotech (ALVO) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
ALVO
Earnings
- 11/12/25 - Beat
ALVO
Sec Filings
- 3/19/26 - Form 6-K
- 3/12/26 - Form SCHEDULE
- 2/27/26 - Form 6-K
- ALVO's page on the SEC website